
改善全球员工福祉可以创造数万亿美元的经济价值
请想象一个这样的世界:雇主基于已有的证据,对其员工的健康进行投资。而作为回报,他们也获得了许多好处:他们的员工、业务和所在社群都能更蒸蒸日上、蓬勃发展。当雇主能够解决工作与健康之间固有的联系时,有利于企业发展的积极机会便会随之涌现。
Lars Hartenstein cofounded and coleads the McKinsey Health Institute (MHI), a global, non-profit-generating institute within the firm. He is particularly passionate about healthy longevity and metabolic health. Grounded in his academic background in economics, medicine, government, and scientific methods, Lars is always looking for new avenues to drive impact across stakeholders and sectors.
Before his role with MHI, Lars was a cofounder and coleader of McKinsey’s European Social Sector Hub. He also served life sciences companies, global health organizations, and national health systems on strategic and operational themes. His work brought him to over 50 countries on six continents.
With 20 years of experience in global health, life sciences, and impact finance, he has a track record in building coalitions, scaling innovations, and fostering the broader use of data and analytics to advance social objectives.
Lars has authored numerous publications and articles, mostly on health-related topics, that have received more than one million reads.
He is a non-executive chair of the Societal Impact Financing Initiative (SciFi) and is on the steering committee of the Trinity Challenge, a coalition established to improve the use of innovation in data and analytics to address global health priorities.
请想象一个这样的世界:雇主基于已有的证据,对其员工的健康进行投资。而作为回报,他们也获得了许多好处:他们的员工、业务和所在社群都能更蒸蒸日上、蓬勃发展。当雇主能够解决工作与健康之间固有的联系时,有利于企业发展的积极机会便会随之涌现。
Imaginemos un mundo en el que las empresas invierten en la salud de sus empleados basándose en pruebas científicas. A cambio, obtienen múltiples beneficios de esas inversiones: sus emplea...
Imagine a world in which employers make evidence-based investments in the health of their employees. In return, they reap a manifold benefit to those investments: their employees thrive, ...
Pause for a moment to imagine — what if the world had the infrastructure to identify an emerging or re-emerging infectious disease threat before it became widespread? What if decision-mak...